5,7-dihydroxytryptamine has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abud-Hawa, M; Aluf, Y; Avital, A; Finberg, JPM; Haick, H; Jeries, R; Khatib, S; Loboda, Y; Nakhleh, MK; Vaya, J; Zubedat, S | 1 |
| Bioulac, B; De Deurwaerdère, P; Gross, C; Navailles, S | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and Parkinsonian Disorders
| Article | Year |
|---|---|
Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.
Topics: 5,7-Dihydroxytryptamine; alpha-Synuclein; Animals; Breath Tests; Corpus Striatum; Discriminant Analysis; Dopaminergic Neurons; Factor Analysis, Statistical; Male; Mutation; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Rats, Transgenic; Serotonergic Neurons; Volatile Organic Compounds | 2018 |
Serotonergic neurons mediate ectopic release of dopamine induced by L-DOPA in a rat model of Parkinson's disease.
Topics: 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Brain; Citalopram; Cobra Neurotoxin Proteins; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Extracellular Fluid; Levodopa; Male; Microdialysis; Oxidopamine; Parkinsonian Disorders; Presynaptic Terminals; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Sympatholytics; Synaptic Transmission | 2010 |